Page 51 - e-book CPG - Bipolar Disorder
P. 51

CLINICAL PRACTICE GUIDELINES              MANAGEMENT OF BIPOLAR DISORDER (2ND ED.)


            46.   Cullen  C,  Kappelmann  N,  Umer  M,  et  al.  Efficacy  and  acceptability  of  pharmacotherapy  for
                comorbid anxiety symptoms in bipolar disorder: A systematic review and meta-analysis. Bipolar
                Disord. 2021;23(8):754-66.
            47.   Strawbridge  R,  Kurana  S,  Kerr-Gaffney  J,  et  al.  A  systematic  review  and  meta-analysis  of
                treatments for rapid cycling bipolar disorder. Acta Psychiatr Scand. 2022;146(4):290-311.
            48.   Kato M, Adachi N, Kubota Y, et al. Clinical features related to rapid cycling and one-year euthymia
                in  bipolar disorder patients: A multicenter treatment survey for bipolar disorder  in psychiatric
                clinics (MUSUBI). J Psychiatr Res. 2020;131:228-34.
            49.   Zhihan G, Fengli S, Wangqiang L, et al. Lamotrigine and Lithium Combination for Treatment of
                Rapid Cycling Bipolar Disorder: Results From Meta-Analysis. Front Psychiatry. 2022;13:913051.
            50.   Verdolini N, Hidalgo-Mazzei D, Del Matto L, et al. Long-term treatment of bipolar disorder type I:
                A systematic and critical review of clinical guidelines with derived practice algorithms. Bipolar
                Disord. 2021;23(4):324-40.
            51.   Liu B, Zhang Y, Fang H, et al. Efficacy and safety of long-term antidepressant treatment for
                bipolar disorders - A meta-analysis of randomized controlled trials. J Affect Disord. 2017;223:41-
                8.
            52.   Prajapati AR, Wilson J, Song F, et al. Second-generation antipsychotic long-acting injections in
                bipolar disorder: Systematic review and meta-analysis. Bipolar Disord. 2018;20(8):687-96.
            53.   Delgado A, Velosa J, Zhang J, et al. Clozapine in bipolar disorder: A systematic review and meta-
                analysis. J Psychiatr Res. 2020;125:21-7.
            54.   Schoeyen  HK,  Kessler  U,  Andreassen  OA,  et  al.  Treatment-resistant  bipolar  depression:  a
                randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological
                treatment. Am J Psychiatry. 2015;172(1):41-51.
            55.   Kessler  U,  Schoeyen  HK,  Andreassen  OA,  et  al.  The  effect  of  electroconvulsive  therapy  on
                neurocognitive  function  in  treatment-resistant  bipolar  disorder  depression.  J  Clin  Psychiatry.
                2014;75(11):e1306-13.
            56.   Tor PC, Bin Abdin E. Mirror Readmission Study of the Association of Electroconvulsive Therapy
                With  1-Year  Mood  Disorder  Readmissions  in  a  Tertiary  Mood  Disorder  Unit.  J  ECT.
                2020;36(2):111-4.
            57.   Minnai  GP,  Salis  P,  Manchia  M,  et  al. What  happens  to  the  course  of  bipolar  disorder  after
                electroconvulsive therapy? J Affect Disord. 2016;195:180-4.
            58.   Kaster TS, Vigod SN, Gomes T, et al. Risk of serious medical events in patients with depression
                treated with electroconvulsive therapy: a propensity score-matched, retrospective cohort study.
                Lancet Psychiatry. 2021;8(8):686-95.
            59.   Ministry of Health Malaysia. Guideline on Electroconvulsive Therapy for Ministry of Health Basis,
                Practicality & Policies. Putrajaya : MoH; 2021.
            60.   Nguyen TD, Hieronymus F, Lorentzen R, et al. The efficacy of repetitive transcranial magnetic
                stimulation  (rTMS)  for  bipolar  depression:  A  systematic  review  and  meta-analysis.  J  Affect
                Disord. 2021;279:250-5.
            61.   Konstantinou  G,  Hui  J,  Ortiz  A,  et  al.  Repetitive  transcranial  magnetic  stimulation  (rTMS)  in
                bipolar disorder: A systematic review. Bipolar Disord. 2022;24(1):10-26.
            62.   McIntyre  RS,  Lee  Y,  Rodrigues  NB,  et  al.  Repetitive  transcranial  magnetic  stimulation  for
                cognitive function in adults with bipolar disorder: A pilot study. J Affect Disord. 2021;293:73-7.
            63.   Matsuda  Y,  Kito  S,  Igarashi  Y,  et  al.  Efficacy  and  Safety  of  Deep  Transcranial  Magnetic
                Stimulation  in  Office Workers  with  Treatment-Resistant  Depression:  A  Randomized,  Double-
                Blind, Sham-Controlled Trial. Neuropsychobiology. 2020;79(3):208-13.
            64.   Tavares DF, Suen P, Rodrigues Dos Santos CG, et al. Treatment of mixed depression with theta-
                burst stimulation (TBS): results from a double-blind, randomized, sham-controlled clinical trial.
                Neuropsychopharmacology. 2021;46(13):2257-65.
            65.   Loo  CK,  Husain  MM,  McDonald  WM,  et  al.  International  randomized-controlled  trial  of
                transcranial Direct Current Stimulation in depression. Brain Stimul. 2018;11(1):125-33.
            66.   Sampaio-Junior B, Tortella G, Borrione L, et al. Efficacy and Safety of Transcranial Direct Current
                Stimulation as an Add-on Treatment for Bipolar Depression: A Randomized Clinical Trial. JAMA
                Psychiatry. 2018;75(2):158-66.
            67.   Tortella G, Sampaio-Junior B, Moreno ML, et al. Cognitive outcomes of the bipolar depression
                electrical treatment trial (BETTER): a randomized, double-blind, sham-controlled study. Eur Arch
                Psychiatry Clin Neurosci. 2021;271(1):93-100.
            68.   Zhou TH, Dang WM, Ma YT, et al. Clinical efficacy, onset time and safety of bright light therapy
                in  acute  bipolar  depression  as  an  adjunctive  therapy:  A  randomized  controlled  trial.  J  Affect
                Disord. 2018;227:90-6.
                                          37

                                          37
   46   47   48   49   50   51   52   53   54   55   56